Bonnesen T, Tikjøb G, Kamper A L, Nielsen A M, Andersen J T, Jørgensen S J
Urol Int. 1984;39(5):318-20. doi: 10.1159/000281002.
75 patients were randomized to be treated with either emepronium bromide (Cetiprin) 200 mg 4 times a day or placebo after transurethral resection of the prostate. The patients were evaluated urodynamically pre- and postoperatively, and further evaluated by micturition symptom charts. No significant differences in symptoms or objective findings were found between the patients treated with emepronium bromide and those treated with placebo.
75例患者在经尿道前列腺切除术后被随机分为两组，一组每天4次服用200毫克溴美喷酯（西替普明），另一组服用安慰剂。对患者在术前和术后进行尿动力学评估，并通过排尿症状图表进一步评估。服用溴美喷酯的患者与服用安慰剂的患者在症状或客观检查结果上未发现显著差异。
